Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins

Published:2012-05 Issue:5 Volume:23 Page:484-491
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Ayala-Breton Camilo¹,Barber Glen N.²,Russell Stephen J.¹³,Peng Kah-Whye¹⁴

Affiliation:

1. Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905.

2. Department of Medicine, University of Miami School of Medicine, Miami, FL 33136.

3. Division of Hematology, Mayo Clinic, Rochester, MN 55905.

4. Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2011.146

Reference39 articles.

1. Vesicular Stomatitis Virus (VSV) Therapy of Tumors

2. Defective translational control facilitates vesicular stomatitis virus oncolysis

3. Preferential targeting of vesicular stomatitis virus to breast cancer cells

4. Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells;Molecular Therapy: Oncology;2024-06

2. EGFR core fucosylation, induced by hepatitis C virus, promotes TRIM40-mediated-RIG-I ubiquitination and suppresses interferon-I antiviral defenses;Nature Communications;2024-01-22

3. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy;Journal of Translational Medicine;2023-07-25

4. Oncolytic Viruses and Viral Gene Therapy Vectors: Principles of Safety;Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs);2023

5. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation;Viral Vectors in Cancer Immunotherapy;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3